Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.0900 (-1.75%) ($30.6000 - $33.1300) on Fri. May. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.09% (three month average) | RSI | 44 | Latest Price | $32.0900(-1.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -3.2% a day on average for past five trading days. | Weekly Trend | IOVA advances 0.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(46%) ARKG(44%) IWO(42%) ARKK(40%) | Factors Impacting IOVA price | IOVA will decline at least -4.045% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-13%) TBT(-5%) UNG(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.045% (StdDev 8.09%) | Hourly BBV | 0 () | Intraday Trend | -2.3% | | | |
|
Resistance Level | $35.43 | 5 Day Moving Average | $36.25(-11.48%) | 10 Day Moving Average | $36.47(-12.01%) | 20 Day Moving Average | $35.43(-9.43%) | To recent high | -21.7% | To recent low | 64.2% | Market Cap | $4.699b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |